Skip to main content

S 301 — New Jersey

Classifies 7 Hydroxymitragynine as Schedule I drug.

Introduced 222 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • S 301 is a bill in the New Jersey Senate, 222 session, introduced January 13, 2026.
  • Sponsored by Turner, Shirley K. and Corrado, Kristin M., with 2 cosponsors.
  • Current status: introduced.
  • Most recent action (March 16, 2026): Referred to Senate Budget and Appropriations Committee.
  • 1 recorded vote; the most recent, on March 16, 2026, passed 8-0.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Turner, Shirley K., Corrado, Kristin M.

Cosponsors (2): Tiver, Latham, Space, Parker

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed General Assembly, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee Milestone
  2. Senate Reported from Senate Committee, 2nd Reading
  3. Senate Referred to Senate Budget and Appropriations Committee Latest

    Reported favorably out of committee: 8 yes 0 no Passed, 100% yes

Source: Open States. Last checked November 5, 2026. How we keep this accurate ›